Author:
Miernik Arkadiusz,Gratzke Christian
Publisher
Deutscher Arzte-Verlag GmbH
Reference94 articles.
1. Gravas S, Cornu J, Gacci M, et al.: EAU Guidelines on mnagement of non-neurogenic male lower urinary tract symptoms (LUTS), incl. benign prostatic obstruction (BPO). 2019. European Association of Urology 2019. https://uroweb.org/guideline/treatment-of-non-neurogenic-male-luts/ (last accesssed on 19 September 2019).
2. Barry MJ, Fowler FJ Jr, O‘Leary MP, et al.: The American Urological Association symptom index for benign prostatic hyperplasia. The Measurement Committee of the American Urological Association. J Urol 1992; 148: 1549–64
3. Egan KB: The epidemiology of benign prostatic hyperplasia associated with lower urinary tract symptoms: prevalence and incident rates. Urol Clin North Am 2016; 43: 289–97
4. Berry SJ, Coffey DS, Walsh PC, Ewing LL: The development of human benign prostatic hyperplasia with age. J Urol 1984; 132: 474–9
5. Vuichoud C, Loughlin KR: Benign prostatic hyperplasia: epidemiology, economics and evaluation. Can J Urol 2015; 22: 1–6.
Cited by
96 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献